MedTrace Logo

A Dose-finding Study of JMKX003142 in Treatment of Cardiac Edema

NCT06949020 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2025-04-29

No results posted yet for this study

Summary

To Evaluate the Safety, Efficacy, and Pharmacokinetic/Pharmacodynamics Characteristics of JMKX003142 injection Administered Randomly,Double-blind, Placebo-controlled Study in Chinese Cardiacl Edema Patients.

Conditions

  • Cardiac Edema

Interventions

DRUG

JMKX003142 Injection

JMKX003142 injection for experimental groups once daily for five days.

DRUG

JMKX003142 Injection

JMKX003142 injection for experimental groups once daily for five days.

DRUG

JMKX003142 Injection

JMKX003142 injection for experimental groups once daily for five days.

DRUG

JMKX003142 placebo

JMKX003142 placebo for placebo groups once daily for five days.

Sponsors & Collaborators

  • Jemincare

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2027-01-31
Completion
2027-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06949020 on ClinicalTrials.gov